CollPlant gains $10m milestone from AbbVie to develop dermal and soft tissue filler
Longevity Technology - 04-Jul-2023Recombinant human collagen based fillers help advance the field regenerative aesthetics
Join the club for FREE to access the whole archive and other member benefits.
Chief Executive Officer at CollPlant.
Yehiel is a seasoned executive in the biomedical field and brings over two decades of management experience in both high-tech and biotech companies. He joined CollPlant in 2010 and prior to this, Yehiel served as CEO and Co-founder of Regentis Biomaterials Ltd.; Vice-President of Business Development at ProChon BioTech Ltd.; Vice President of Marketing and Business Development at OrthoScan Technologies Ltd.; and Director of Business Development and Business Unit Manager at Kulicke and Soffa Industries, Inc. Yehiel holds a BSc and an MSc degree in Mechanical Engineering from the Technion-Israel Institute of Technology.
Visit website: https://collplant.com/about/
See also: CollPlant - Regenerative and aesthetic medicine company focused on medical aesthetics and 3D bioprinting of tissues and organs.
Details last updated 08-May-2020
Recombinant human collagen based fillers help advance the field regenerative aesthetics
Received $5M investment from Martin Schlaff's Alpha Capital. Bioprinted tissues based on technol...